Skip to content

The Wellbeing Program: A randomized controlled trial of internet based treatment of anxiety and depression

A randomized controlled trial of Internet based treatment for anxiety and depression comparing immediate treatment vs. delayed treatment on symptoms of anxiety and depression.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000247077
Enrollment
80
Registered
2010-03-24
Start date
2010-03-25
Completion date
2010-06-25
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project is part of a research program funded by the NHMRC (No. 630560) to develop and evaluate Internet based transdiagnostic treatment programs for people with anxiety and depression. This preliminary project examines the efficacy of a treatment program for people with depression, social phobia and/or panic disorder (with or without agoraphobia) and/or GAD. We expect that people in either immediate or delayed treatment groups will report similar benefit following the active component of their program.

Interventions

Participants will be randomly assigned to one of two groups: 1) an immediate treatment group, or; 2) a delayed treatment group also known as a waitlist control group (beginnning the program 11 weeks after the immediate treatment group begin). All participants will meet Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for depression, and/or social phobia and/or panic disorder (with or without agoraphobia) and/or generalised anxiety disorder (GAD). All participan

Participants will be randomly assigned to one of two groups: 1) an immediate treatment group, or; 2) a delayed treatment group also known as a waitlist control group (beginnning the program 11 weeks after the immediate treatment group begin). All participants will meet Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for depression, and/or social phobia and/or panic disorder (with or without agoraphobia) and/or generalised anxiety disorder (GAD). All participants will complete 8 lessons of Internet based treatment about management of symptoms of depression and anxiety. One lesson will be completed every 7 to 10 days. Each lesson will take about 15 minutes to complete. Participants will also have access to summaries of each lesson, and will read anonymous stories about other people with anxiety, taking a further 20 minutes per summary. All participants will also receive automatic email and weekly reminder phone calls by a clinical psychologist, and have access to a clinician-moderated online forum discussing content of the program. The duration of the reminder emails/phone calls and contribution to the forum is expected to be 5-10 minutes per week. The duration of the program is 10 weeks, but participants in the immediate treatment group will be contacted 3 months post program and asked to complete follow-up questionnaires. Study questionnaires will be administered at application, pre-education, post-education, and at 3-months post-education. These will take about 20-30 minutes to complete. The treatment materials are based on the Anxiety and Sadness Programs, which apply cognitive behavioural techniques.

Sponsors

Clinical Research Unit for Anxiety and Depression (CRUfAD), School of Psychiatry, University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-Meet DSM-IV criteria for major depressive disorder, social phobia and/or panic disorder (with or without agoraphobia) and/or GAD - Internet access + printer access - Australian resident - Males and females

Exclusion criteria

- Current substance abuse/dependence - Psychotic disorder - Current or planned psychological treatment during study duration - Change in medications during last 1 month or intended change during study duration - Current use of benzodiazepines or beta-blockers.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026